They might. If they plan on starting multiple new phase 2 trials - sepsis, UTI, DFUs. Plus moving pre-clinical assets into new clinical trials. It all gets quite expensive.
But hopefully it's updated trial results from the burns study.
They might. If they plan on starting multiple new phase 2 trials...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.015(3.00%) |
Mkt cap ! $112.3M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 51.5¢ | 48.5¢ | $10.74K | 21.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15892 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.5¢ | 230 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |